{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T03:00:17Z","timestamp":1768878017036,"version":"3.49.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2015,5,9]],"date-time":"2015-05-09T00:00:00Z","timestamp":1431129600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1007\/s00198-015-3158-2","type":"journal-article","created":{"date-parts":[[2015,5,8]],"date-time":"2015-05-08T06:43:57Z","timestamp":1431067437000},"page":"2441-2447","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["A double-blind, randomized, Phase III, multicenter study in 358 pediatric subjects receiving isotretinoin therapy demonstrates no effect on pediatric bone mineral density"],"prefix":"10.1007","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2359-9736","authenticated-orcid":false,"given":"K. B.","family":"Hoover","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. G.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N. C.","family":"Galante","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. B.","family":"Langman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,5,9]]},"reference":[{"key":"3158_CR1","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0140-6736(11)60321-8","volume":"379","author":"HC Williams","year":"2012","unstructured":"Williams HC, Dellavalle RP, Garner S (2012) Acne vulgaris. Lancet 379:361\u2013372","journal-title":"Lancet"},{"key":"3158_CR2","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1001\/archderm.135.8.961","volume":"135","author":"SA Leachman","year":"1999","unstructured":"Leachman SA, Insogna KL, Katz L, Ellison A, Milstone LM (1999) Bone densities in patients receiving isotretinoin for cystic acne. Arch Dermatol 135:961\u2013965","journal-title":"Arch Dermatol"},{"key":"3158_CR3","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/S0190-9622(82)70148-3","volume":"7","author":"LM Milstone","year":"1982","unstructured":"Milstone LM, McGuire J, Ablow RC (1982) Premature epiphyseal closure in a child receiving oral 13-cis-retinoic acid. J Am Acad Dermatol 7:663\u2013666","journal-title":"J Am Acad Dermatol"},{"key":"3158_CR4","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/dth.12084","volume":"26","author":"SC On","year":"2013","unstructured":"On SC, Zeichner J (2013) Isotretinoin updates. Dermatol Ther 26:377\u2013389","journal-title":"Dermatol Ther"},{"key":"3158_CR5","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/BF00367754","volume":"16","author":"JP Lawson","year":"1987","unstructured":"Lawson JP, McGuire J (1987) The spectrum of skeletal changes associated with long-term administration of 13-cis-retinoic acid. Skelet Radiol 16:91\u201397","journal-title":"Skelet Radiol"},{"key":"3158_CR6","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1001\/archderm.1992.01680170058005","volume":"128","author":"LM Milstone","year":"1992","unstructured":"Milstone LM, Ellison AF, Insogna KL (1992) Serum parathyroid hormone level is elevated in some patients with disorders of keratinization. Arch Dermatol 128:926\u2013930","journal-title":"Arch Dermatol"},{"key":"3158_CR7","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1001\/archderm.1995.01690230041007","volume":"131","author":"JJ DiGiovanna","year":"1995","unstructured":"DiGiovanna JJ, Sollitto RB, Abangan DL, Steinberg SM, Reynolds JC (1995) Osteoporosis is a toxic effect of long-term etretinate therapy. Arch Dermatol 131:1263\u20131267","journal-title":"Arch Dermatol"},{"key":"3158_CR8","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1001\/archderm.1996.03890310053007","volume":"132","author":"DJ Margolis","year":"1996","unstructured":"Margolis DJ, Attie M, Leyden JJ (1996) Effects of isotretinoin on bone mineralization during routine therapy with isotretinoin for acne vulgaris. Arch Dermatol 132:769\u2013774","journal-title":"Arch Dermatol"},{"key":"3158_CR9","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1111\/j.1365-4632.2008.03534.x","volume":"47","author":"NS Tekin","year":"2008","unstructured":"Tekin NS, Ozdolap S, Sarikaya S, Keskin SI (2008) Bone mineral density and bone turnover markers in patients receiving a single course of isotretinoin for nodulocystic acne. Int J Dermatol 47:622\u2013625","journal-title":"Int J Dermatol"},{"key":"3158_CR10","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1111\/j.1468-3083.2006.01505.x","volume":"20","author":"BS Erdogan","year":"2006","unstructured":"Erdogan BS, Yuksel D, Aktan S, Ergin S, Kirac FS (2006) The effects of isotretinoin treatment on bone mineral density in patients with nodulocystic acne. J Eur Acad Dermatol Venereol 20:1006\u20131007","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"3158_CR11","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.jaad.2004.04.032","volume":"51","author":"JJ DiGiovanna","year":"2004","unstructured":"DiGiovanna JJ, Langman CB, Tschen EH, Jones T, Menter A, Lowe NJ, Eichenfield L, Hebert AA, Pariser D, Savin RP, Smith SR, Jarratt M, Rodriguez D, Chalker DK, Kempers S, Ling M, Rafal ES, Sullivan S, Kang S, Shah LP, Wu E, Newhouse J, Pak J, Eberhardt DR, Bryce GF, McLane JA, Ondovik M, Chin C, Khoo KC, Rich P (2004) Effect of a single course of isotretinoin therapy on bone mineral density in adolescent patients with severe, recalcitrant, nodular acne. J Am Acad Dermatol 51:709\u2013717","journal-title":"J Am Acad Dermatol"},{"key":"3158_CR12","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.jocd.2007.12.002","volume":"11","author":"S Baim","year":"2008","unstructured":"Baim S, Leonard MB, Bianchi ML, Hans DB, Kalkwarf HJ, Langman CB, Rauch F (2008) Official positions of the International Society for Clinical Densitometry and executive summary of the 2007 ISCD Pediatric Position Development Conference. J Clin Densitom 11:6\u201321","journal-title":"J Clin Densitom"},{"key":"3158_CR13","doi-asserted-by":"crossref","first-page":"897","DOI":"10.2214\/AJR.10.5416","volume":"196","author":"R Lorente-Ramos","year":"2011","unstructured":"Lorente-Ramos R, Azpeitia-Arman J, Munoz-Hernandez A, Garcia-Gomez JM, Diez-Martinez P, Grande-Barez M (2011) Dual-energy x-ray absorptiometry in the diagnosis of osteoporosis: a practical guide. AJR Am J Roentgenol 196:897\u2013904","journal-title":"AJR Am J Roentgenol"},{"key":"3158_CR14","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1001\/archdermatol.2010.59","volume":"146","author":"P Vestergaard","year":"2010","unstructured":"Vestergaard P, Rejnmark L, Mosekilde L (2010) High-dose treatment with vitamin A analogues and risk of fractures. Arch Dermatol 146:478\u2013482","journal-title":"Arch Dermatol"},{"key":"3158_CR15","first-page":"665","volume":"13","author":"GF Webster","year":"2014","unstructured":"Webster GF, Leyden JJ, Gross JA (2014) Results of a Phase III, double-blind, randomized, parallel-group, non-inferiority study evaluating the safety and efficacy of isotretinoin-lidose in patients with severe recalcitrant nodular acne. J Drugs Dermatol 13:665\u2013670","journal-title":"J Drugs Dermatol"},{"key":"3158_CR16","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.jaad.2013.05.036","volume":"69","author":"GF Webster","year":"2013","unstructured":"Webster GF, Leyden JJ, Gross JA (2013) Comparative pharmacokinetic profiles of a novel isotretinoin formulation (isotretinoin-Lidose) and the innovator isotretinoin formulation: a randomized, 4-treatment, crossover study. J Am Acad Dermatol 69:762\u2013767","journal-title":"J Am Acad Dermatol"},{"key":"3158_CR17","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1210\/jc.2009-2057","volume":"95","author":"BS Zemel","year":"2010","unstructured":"Zemel BS, Leonard MB, Kelly A, Lappe JM, Gilsanz V, Oberfield S, Mahboubi S, Shepherd JA, Hangartner TN, Frederick MM, Winer KK, Kalkwarf HJ (2010) Height adjustment in assessing dual energy x-ray absorptiometry measurements of bone mass and density in children. J Clin Endocrinol Metab 95:1265\u20131273","journal-title":"J Clin Endocrinol Metab"},{"key":"3158_CR18","first-page":"1","volume":"314","author":"RJ Kuczmarski","year":"2000","unstructured":"Kuczmarski RJ, Ogden CL, Grummer-Strawn LM, Flegal KM, Guo SS, Wei R, Mei Z, Curtin LR, Roche AF, Johnson CL (2000) CDC growth charts: United States. Adv Data 314:1\u201327","journal-title":"Adv Data"},{"key":"3158_CR19","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.jocd.2014.01.007","volume":"17","author":"CM Gordon","year":"2014","unstructured":"Gordon CM, Leonard MB, Zemel BS, International Society for Clinical Densitometry (2014) 2013 Pediatric Position Development Conference: executive summary and reflections. J Clin Densitom 17:219\u2013224","journal-title":"J Clin Densitom"},{"key":"3158_CR20","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1515\/JPEM.2006.19.3.213","volume":"19","author":"JC Desmangles","year":"2006","unstructured":"Desmangles JC, Lappe JM, Lipaczewski G, Haynatzki G (2006) Accuracy of pubertal Tanner staging self-reporting. J Pediatr Endocrinol Metab 19:213\u2013221","journal-title":"J Pediatr Endocrinol Metab"},{"key":"3158_CR21","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1002\/jbmr.473","volume":"26","author":"JA Shepherd","year":"2011","unstructured":"Shepherd JA, Wang L, Fan B, Gilsanz V, Kalkwarf HJ, Lappe J, Lu Y, Hangartner T, Zemel BS, Fredrick M, Oberfield S, Winer KK (2011) Optimal monitoring time interval between DXA measures in children. J Bone Miner Res 26:2745\u20132752","journal-title":"J Bone Miner Res"},{"key":"3158_CR22","unstructured":"Roche Pharmaceuticals (2010) Medication guide accutane. 2014"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-015-3158-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00198-015-3158-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-015-3158-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T11:15:23Z","timestamp":1558610123000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00198-015-3158-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5,9]]},"references-count":22,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["3158"],"URL":"https:\/\/doi.org\/10.1007\/s00198-015-3158-2","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,5,9]]}}}